Welcome to RBC Life Sciences
Company Shop Now Join Now
Español | 한국어| Canada

About RBC



search blogs
share it
blog it

RBC Life Sciences Opens Training Center in Los Angeles

Irving, TX – (June 2, 2008) – RBC Life Sciences (OTC BB: RBCL) hosted a successful grand opening of its Los Angeles training center on Saturday, May 24. This unique center is open to all RBC Independent Associates and provides Southern California representatives with direct access to RBC products, networking opportunities and training. RBC Associates and their guests who attended the grand opening of the new office had the opportunity to network and learn more about RBC's business and its products.

"Education and training are the cornerstones of our business," stated Director of Sales Kevin Young. "This new facility will serve our associates well and will give RBC a valuable presence in what is already a very strong market for us."

The Los Angeles office is located on Wilshire Boulevard, which is accessible and convenient to the entire Southern California area. This is RBC's first training center in the United States, and management believes the center has great potential for the company. 

"The success of this facility will assist RBC in determining future training center locations," said President John Price. "RBC received a great deal of support from the local community, and we were impressed with the community's strong commitment to health and nutrition."

RBC Life Sciences develops, manufactures and markets high quality nutritional supplements and personal care products to a growing population of consumers seeking wellness and a healthy lifestyle. Under its MPM Medical brand, RBC also develops and markets to health care professionals in the United States proprietary prescription and nonprescription products for advanced wound care and pain management. All products are tested for quality assurance in-house, and by outside independent laboratories, to comply with regulations in the U.S. and in more than thirty countries in which the products are distributed.  For more information, visit the Company's Web site at www.rbclifesciences.com.

The statements above, other than statements of historical facts, may be forward‑looking. Actual events will be dependent upon a number of factors and risks including but not limited to changes in plans by the Company's management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange Commission.
 

Contact:
Halliburton Investor Relations
Geralyn DeBusk, 972-458-8000
or
Deidra Roy,
droy@halliburtonir.com
or
Chase Zavoina, 972-458-8000

attachment
(17 KB)

 

 Email Page    Print
Copyright RBC Life Sciences 2008